Stock listing
A3EURE Stock Price, News, Filings & Events — Pharmadrug, Inc.
Selected listing: A3EURE · LSX · EUR · DE
This page tracks Pharmadrug, Inc.'s A3EURE:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3EURE:LSX. A3EURE:LSX is the stock-level entry point for investors researching Pharmadrug, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3EURE:LSX
- Asset type
- Stock
- Market cap
- $484,984
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- LSX
- Currency
- EUR
Pharmadrug, Inc. A3EURE:LSX stock context
This page tracks Pharmadrug, Inc.'s A3EURE:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3EURE:LSX. A3EURE:LSX is the stock-level entry point for investors researching Pharmadrug, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Pharmadrug, Inc.
PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring
January 5, 2026
PharmaDrug Announces Debt Restructuring
October 31, 2025
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
October 30, 2025
PharmaDrug Inc.: Correction to News Release Dated July 30, 2025
July 30, 2025
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.
July 30, 2025
Research Pharmadrug, Inc.
Pharmadrug, Inc. investor report
Review AI stock analysis and investor report context for A3EURE:LSX.
Pharmadrug, Inc. company profile
View the public company page for Pharmadrug, Inc. on 6ix.
Pharmadrug, Inc. news
Read company news and market updates connected to Pharmadrug, Inc..
Pharmadrug, Inc. investor events
Find investor webinars, events, and replay context for Pharmadrug, Inc..
Alternate listings
PHRX:CSE
CA · CAD
Alternate listing for Pharmadrug, Inc.; the primary context on this page is A3EURE:LSX.
G11:GETTEX
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is A3EURE:LSX.
LMLLF:OTC
US · USD
Alternate listing for Pharmadrug, Inc.; the primary context on this page is A3EURE:LSX.
PHRX:NEO
CA · CAD
Alternate listing for Pharmadrug, Inc.; the primary context on this page is A3EURE:LSX.
A3EURE:LS
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is A3EURE:LSX.
G11:MUN
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is A3EURE:LSX.
G11:FWB
DE · EUR
Alternate listing for Pharmadrug, Inc.; the primary context on this page is A3EURE:LSX.